Cited by 278Artificial Intelligence in Healthcare and EducationCutaneous Melanoma Detection and ManagementAI in cancer detection

Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study

Open access
Nelson, Caroline A., Pérez-Chada, Lourdes Maria, Creadore, Andrew, Li, Sara Jiayang, Lo, Kelly, Manjaly, Priya, Pournamdari, Ashley Bahareh, Tkachenko, Elizabeth +5 more·2020·JAMA Dermatology

Abstract

Importance: The use of artificial intelligence (AI) is expanding throughout the field of medicine. In dermatology, researchers are evaluating the potential for direct-to-patient and clinician decision-support AI tools to classify skin lesions. Although AI is poised to change how patients engage in health care, patient perspectives remain poorly understood. Objective: To explore how patients conceptualize AI and perceive the use of AI for skin cancer screening. Design, Setting, and Participants: A qualitative study using a grounded theory approach to semistructured interview analysis was conducted in general dermatology clinics at the Brigham and Women's Hospital and melanoma clinics at the Dana-Farber Cancer Institute. Forty-eight patients were enrolled. Each interview was independently coded by 2 researchers with interrater reliability measurement; reconciled codes were used to assess code frequency. The study was conducted from May 6 to July 8, 2019. Main Outcomes and Measures: Artificial intelligence concept, perceived benefits and risks of AI, strengths and weaknesses of AI, AI implementation, response to conflict between human and AI clinical decision-making, and recommendation for or against AI. Results: Of 48 patients enrolled, 26 participants (54%) were women; mean (SD) age was 53.3 (21.7) years. Sixteen patients (33%) had a history of melanoma, 16 patients (33%) had a history of nonmelanoma skin cancer only, and 16 patients (33%) had no history of skin cancer. Twenty-four patients were interviewed about a direct-to-patient AI tool and 24 patients were interviewed about a clinician decision-support AI tool. Interrater reliability ratings for the 2 coding teams were κ = 0.94 and κ = 0.89. Patients primarily conceptualized AI in terms of cognition. Increased diagnostic speed (29 participants [60%]) and health care access (29 [60%]) were the most commonly perceived benefits of AI for skin cancer screening; increased patient anxiety was the most commonly perceived risk (19 [40%]). Patients perceived both more accurate diagnosis (33 [69%]) and less accurate diagnosis (41 [85%]) to be the greatest strength and weakness of AI, respectively. The dominant theme that emerged was the importance of symbiosis between humans and AI (45 [94%]). Seeking biopsy was the most common response to conflict between human and AI clinical decision-making (32 [67%]). Overall, 36 patients (75%) would recommend AI to family members and friends. Conclusions and Relevance: In this qualitative study, patients appeared to be receptive to the use of AI for skin cancer screening if implemented in a manner that preserves the integrity of the human physician-patient relationship.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamadermatol.2019.5014

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Institute of Medicine Committee on Quality of Health Care. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.

Cited by

Sorted by citations

Authors
Nelson, C. A., Pérez-Chada, L. M., Creadore, A., Li, S. J., Lo, K., Manjaly, P., Pournamdari, A. B., Tkachenko, E., Barbieri, J. S., Ko, J. M., Menon, A. V., Hartman, R. I., & Mostaghimi, A.
Affiliations
  • Yale University (US)
  • Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
  • Boston University (US)
  • Brigham and Women's Hospital (US)
  • University of Pennsylvania (US)
  • Stanford Medicine (US)
Corresponding author
Mostaghimi, Arash
Venue
JAMA Dermatology
Published
2020-05-01
Volume
156
Issue
5
Pages
501
ISSN
2168-6068 (ISSN-L)
OpenAlex
W3012449740
Cited by
278
References
18
Citations by year
2026: 44 · 2025: 57 · 2024: 55 · 2023: 45 · 2022: 37 · 2021: 32 · 2020: 8
FWCI
8.98
Type
journal article
Language
en
Open access
Locations
  • JAMA Dermatology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR001863)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007465)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
artificial intelligence, skin cancer screening, patient perspectives, melanoma, non-melanoma skin cancer, clinician decision support, human-AI collaboration, patient anxiety, diagnostic accuracy, patient acceptance of AI, health care access, dermatology clinic, patient-provider communication, shared decision-making
MeSH terms
Adult, Aged, Artificial Intelligence, Biopsy, Female, Health Services Accessibility, Humans, Interviews as Topic, Male, Mass Screening, Melanoma, Middle Aged, Patient Acceptance of Health Care, Physician-Patient Relations, Skin Neoplasms, Reproducibility of Results, Observer Variation, Qualitative Research, Early Detection of Cancer, Grounded Theory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review